| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/25/2001 | EP1117417A1 Pharmaceutically active plant preparation for the treatment of migraine |
| 07/25/2001 | EP1117414A1 Reduction of oxidative stress factors |
| 07/25/2001 | EP1117409A2 Use of benzenesulfonyl(thio)ureas for the treatment of dysfunctions of the autonomous nervous system |
| 07/25/2001 | EP1117407A1 Oral dosage formulations comprising (2s, 3s,5r)-2-(3,5-difluorophenyl) -3,5-dimethyl-2-morpholinol and an effective stabilizing amount of alginic acid |
| 07/25/2001 | EP1117403A1 Mglur5 antagonists for the treatment of pain and anxiety |
| 07/25/2001 | EP1117399A1 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP1117394A1 Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
| 07/25/2001 | EP1117390A1 Mucosal originated drug delivery systems and animal applications |
| 07/25/2001 | EP1117389A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
| 07/25/2001 | EP1117370A1 CONTROLLED RELEASE FROM COPOLYMERS OF ACRYLIC OR METHACRYLIC ACID/L-DOPA, ACRYLIC OR METHACRYLIC ACID/L-$g(a)-METHYL DOPA, ACRYLIC OR METHACRYLIC ACID/CARBIDOPA AND THEIR COMBINATIONS |
| 07/25/2001 | EP0879230B1 Optically active phenyl pyrimidine derivative as analgesic agent |
| 07/25/2001 | EP0814770B1 Process for the preparation of a solid pharmaceutical dosage form |
| 07/25/2001 | EP0772610B9 Dihydrobenzofuranes |
| 07/25/2001 | EP0765322B1 Indole derivatives as prodrugs of 5-ht1-like receptor agonists |
| 07/25/2001 | EP0741709B1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists |
| 07/25/2001 | EP0684944B1 Coupling product obtained from hystamine and an amino acid |
| 07/25/2001 | CN1305493A Novel cyclosporins |
| 07/25/2001 | CN1305491A Crystalline forms of 1S-[1a(pha(2S, 3R), 9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]-amino] actahydro-6H-piridazino [1,2-A][1,2] diazepin-1-carboxamide |
| 07/25/2001 | CN1305481A Piperazino derivatives as neurokinin antafonists |
| 07/25/2001 | CN1305480A Pyrolo [2,3-d] pyrimidine compounds |
| 07/25/2001 | CN1305479A Pyrrolo [2,3-d] pyrmidine compounds |
| 07/25/2001 | CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1305475A Chemical synthesis of morpholine derivatives |
| 07/25/2001 | CN1305474A Paroxetine maleate |
| 07/25/2001 | CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein |
| 07/25/2001 | CN1305465A Aryl alkanoylpyridazines |
| 07/25/2001 | CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 07/25/2001 | CN1305460A Process for preparation of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole |
| 07/25/2001 | CN1305383A Regulation of tyrosine bydroxylase |
| 07/25/2001 | CN1305379A Method of treatment |
| 07/25/2001 | CN1305377A Methods for increasing levels of acetylcholine |
| 07/25/2001 | CN1305343A Methods for increasing levels of acetylchotine |
| 07/25/2001 | CN1304936A Quinoline-4-radical derivative II |
| 07/25/2001 | CN1304929A 4-hydroxy-4-phenyl piperidine derivative and medicine containing said derivative |
| 07/25/2001 | CN1304772A Process for preparing medicine to treating diseases in peripheral nerve system and male genetic defect |
| 07/25/2001 | CN1304754A Health-preserving capsule |
| 07/25/2001 | CN1304753A Ganlu pill and its preparing process |
| 07/25/2001 | CN1304736A Medicine for treating diabetes nerve end inflammation |
| 07/25/2001 | CN1304723A Tanshinone compounds containing dihydrofuran ring structure used for medicine to treat hepatic encephalopathy |
| 07/25/2001 | CN1068879C Dihydrobenzofuranes |
| 07/24/2001 | US6265612 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 07/24/2001 | US6265578 Matrix metalloprotease inhibitors |
| 07/24/2001 | US6265563 Nucleotide sequences probes for use as diagnostic tools and drug screening |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders |
| 07/24/2001 | US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers |
| 07/24/2001 | US6265441 Nitric oxide synthase inhibitor |
| 07/24/2001 | US6265437 Alcoholism |
| 07/24/2001 | US6265426 Triazole derivatives |
| 07/24/2001 | US6265414 Treating sleep disorders using desloratadine |
| 07/24/2001 | US6265408 Sulphonamide derivatives and their use in the treatment of CNS disorders |
| 07/24/2001 | US6265405 Triazine compounds for treatment of CNS disorders |
| 07/24/2001 | US6265175 Incubating components comprising neuroblast and composition to be tested for ability to stimulate or inhibit proliferation or differentiation of the neuroblast to allow composition to bind to neuroblast, culturing, detecting effect |
| 07/24/2001 | CA2240594C 2,7-substituted octahydro-pyrrolo¬1,2-a|pyrazine derivatives |
| 07/24/2001 | CA2220703C Pharmaceutical compositions for the treatment of alcohol addiction |
| 07/24/2001 | CA2193454C Bioadhesive pharmaceutical composition for the controlled release of active ingredients |
| 07/24/2001 | CA2177774C Novel piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds; process_for preparing the same and pharmaceutical compositions containing them |
| 07/24/2001 | CA2174033C Novel pyridine compounds; process for preparing the same and pharmaceutical compositions containing them |
| 07/24/2001 | CA2042112C N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| 07/24/2001 | CA2031588C Substituted cyclohexanols and cyclohexylamines as central nervous system agents |
| 07/24/2001 | CA2030773C Stabilized solutions of psychotropic agents |
| 07/24/2001 | CA2030162C Benzothiazepines |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051520A2 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051492A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors |
| 07/19/2001 | WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | WO2001051482A1 Extraction of flavonoids |
| 07/19/2001 | WO2001051478A1 Method for the preparation of citalopram |
| 07/19/2001 | WO2001051474A2 Polypharmacophoric agents |
| 07/19/2001 | WO2001051473A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 07/19/2001 | WO2001051472A1 New imidazole derivatives |
| 07/19/2001 | WO2001051471A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 07/19/2001 | WO2001051470A1 Phenanthridine-n-oxides |
| 07/19/2001 | WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists |
| 07/19/2001 | WO2001051464A1 Novel vitamin d analogues |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001051453A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors |
| 07/19/2001 | WO2001051064A1 Ph-regulators against oral stereotypies in equines |
| 07/19/2001 | WO2001051047A1 Use of fumaric acid derivatives for treating mitochondrial diseases |
| 07/19/2001 | WO2001051003A2 Use of lipid conjugates in the treatment of disease |
| 07/19/2001 | WO2001050848A2 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005758A3 Indoles and indazoles for the treatment of migraine |
| 07/19/2001 | WO2001005418A3 Tissue regenerating agent |
| 07/19/2001 | WO2001005392A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | WO2001005391A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2001002549A3 Homomeric and heteromeric ampa receptors |
| 07/19/2001 | WO2000076984A8 Novel compounds, their use and preparation |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000073296A3 3-heteroarylalkyl substituted gaba analogs |
| 07/19/2001 | WO2000064485A9 Specifically targeted catalytic antagonists and uses thereof |